FDA AdCom Votes in Favor of Emergency Use Authorization for Pfizer (PFE) and BioNTech's (BNTX) Covid-19 Vaccine in Children 5 to <12 Years

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/30/2026

1. SPY
2. DLR
3. EOSE
4. MU
5. AVAV
6. VSH
7. ENPH
8. BAC
9. NVDA
10. ABVX

Go back to FDA AdCom Votes in Favor of Emergency Use Authorization for Pfizer (PFE) and BioNTech's (BNTX) Covid-19 Vaccine in Children 5 to <12 Years

FDA Advisory Committee Votes in Favor of Granting Emergency Use Authorization for the Pfizer-BioNTech Covid-19 Vaccine in Children 5 to <12 Years

October 26, 2021 6:20 PM EDT

Committee reviewed clinical data showing a favorable safety profile and high vaccine efficacy of 90.7% in children 5 to... More